Currently, there are 179.29M common shares owned by the public and among those 39.63M shares have been available to trade.
The company’s stock has a 5-day price change of 27.65% and 55.00% over the past three months. PTVE shares are trading 26.62% year to date (YTD), with the 12-month market performance up to 40.51% higher. It has a 12-month low price of $8.83 and touched a high of $16.01 over the same period. PTVE has an average intraday trading volume of 319.53K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 29.51%, 40.67%, and 38.59% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Pactiv Evergreen Inc (NASDAQ: PTVE) shares accounts for 23.49% of the company’s 179.29M shares outstanding.
It has a market capitalization of $3.12B and a beta (3y monthly) value of 1.35. The earnings-per-share (ttm) stands at -$0.93. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.83% over the week and 4.24% over the month.
Earnings per share for the fiscal year are expected to increase by 5.81%, and 26.60% over the next financial year.
Looking at the support for the PTVE, a number of firms have released research notes about the stock. Jefferies stated their Buy rating for the stock in a research note on January 19, 2024, with the firm’s price target at $18. UBS coverage for the Pactiv Evergreen Inc (PTVE) stock in a research note released on January 16, 2024 offered a Buy rating with a price target of $19. Citigroup was of a view on January 03, 2024 that the stock is Buy, while BofA Securities gave the stock Buy rating on January 02, 2024, issuing a price target of $14- $16. Citigroup on their part issued Neutral rating on May 23, 2022.
